
There is evidence that treatment with an zzso to tumor necrosis factor alpha zzso zzso improves an animal model of multiple sclerosis zzso and is beneficial in two systemic inflammatory disease in humans, but there are no reports about zzso treatment of zzso zzso we treated two rapidly progressive zzso patients with intravenous infusions of a humanized mouse zzso zzso zzso zzso in an zzso phase I safety trial and monitored their clinical status, zzso brain magnetic resonance imaging zzso and peripheral blood and zzso fluid zzso zzso zzso We did not notice any clinically significant zzso changes in either zzso The number of zzso zzso increased zzso after each treatment in both zzso zzso zzso counts and zzso index increased after each zzso The transient increase in the number of zzso zzso that followed each infusion of zzso together with the increase in cells and zzso in the zzso of each patient suggest that the treatment caused immune zzso and an increase in disease zzso These results suggest that further use of zzso in zzso is not warranted and that studies of other agents that antagonize zzso alpha should be carried out with frequent monitoring of zzso zzso 

